Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

Personalised melanoma vaccine cuts risk of recurrence

Adding a personalised, mRNA-based cancer vaccine to standard immunotherapy after surgery for...

Research project to produce fish-free omega-3

SCU researchers are investigating how to grow omega-3-producing microorganisms more cheaply...

Biodegradable smart patch can detect and treat blood clots

Researchers have developed a biodegradable smart patch that detects pressure changes and releases...

Content from other channels on our network

Novel method to reduce metal waste in manufacturing

ARENA backs hydrogen technology for steelmaking pilot

CSIRO suggests ways Australia can grow battery manufacturing sector

MathWorks certified to provide guidance for AI‍-‍assisted engineering

NSW opens expressions of interest for Bradfield enterprise precinct

Tiny chip may cut AI's growing energy demands

Registrations now open for Clean Up Australia Day 2027

Tilt Renewables awarded five-star rating

"Solar tsunami" may hit businesses as installers go broke

Tiny molecule 'superhighways' to improve industrial processing

pladis program plans to help with a snacking reshape

Food safety testing hub opens in Melbourne

Contamination detection solutions for the food manufacturing industry

Six on the shelf: diverse new food products in November

tna's food packaging solution wins gold at the Good Design Awards 2026